Paradigm Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-850
Closed -$68.3K 394
2020
Q1
$68.3K Hold
850
0.03% 331
2019
Q4
$90.8K Sell
850
-100
-11% -$10.4K 0.03% 350
2019
Q3
$102K Hold
950
0.03% 313
2019
Q2
$96.7K Buy
950
+50
+6% +$4.8K 0.03% 322
2019
Q1
$80.9K Buy
+900
New +$78K 0.02% 327
2017
Q2
Sell
-900
Closed -$88.4K 604
2017
Q1
$88.4K Sell
900
-1,800
-67% -$172K 0.02% 539
2016
Q4
$248K Sell
2,700
-62,550
-96% -$5.39M 0.05% 254
2016
Q3
$5.52M Buy
+65,250
New +$5.48M 0.96% 16
2015
Q4
Sell
-11,300
Closed -$695K 805
2015
Q3
$695K Sell
11,300
-74,600
-87% -$5.21M 0.09% 232
2015
Q2
$6.23M Buy
85,900
+900
+1% +$66.5K 0.69% 30
2015
Q1
$6.53M Buy
+85,000
New +$6.09M 0.73% 22
2014
Q4
Sell
-10,800
Closed -$655K 797
2014
Q3
$655K Buy
+10,800
New +$665K 0.09% 225

Other funds holding DGX

Paradigm Asset Management's DGX Position: Q2 2020 in Review

Paradigm Asset Management sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 850 shares — an estimated $68.3K sold.

Paradigm Asset Management first reported a position in DGX in Q3 2014 and held it in 12 quarters. The position peaked at $6.53M in Q1 2015. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

  • Paradigm Asset Management reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
  • Paradigm Asset Management sold 850 Quest Diagnostics shares in Q2 2020, an estimated $68.3K.
  • Paradigm Asset Management first reported a position in Quest Diagnostics in Q3 2014 and held it in 12 quarters.
  • Paradigm Asset Management's Quest Diagnostics position peaked at $6.53M in Q1 2015.
  • 749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Paradigm Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.